Global Market PresenceThe company has been expanding its services overseas, which is likely to enhance its global presence as clients prefer biologics CXOs that have sites nearby.
Market LeadershipWuXi Biologics is a leading player in the biologics CXO market, holding a 13% global market share and a dominant position in China.
Stable Recurring RevenuesAntibody-drug conjugate and commercial deals are expected to provide stable recurring cash flows, as commercial projects generate significantly more revenue than early-stage projects.